Before you ever uncap a needle, the outcome of an IV start may already be decided. In this special episode of the Super Nurse Podcast, we break down the research behind peripheral IV failure rates, the rise of ultrasound-guided IVs, and why the “blind stick” is no longer acceptable in many patient populations. You’ll learn why traditional IV starts fail up to 69% of the time, how ultrasound guidance boosts first-attempt success to nearly 98%, and how tools like the DIVA score remove ego from escalation decisions. We also explore why vascular access teams (VASTs) save money, preserve veins, and improve patient safety—while reducing unnecessary central lines. If you’ve ever felt the pressure of the pin-cushion effect, this episode reframes IV access as a clinical judgment skill—not luck.
Check out SuperNurse.ai for AI powered learning, comic-book style downloads, and super fun lessons for super nurses!
What’s Really Failing in IV Access
Over 2 billion peripheral IVs are placed globally each year
Traditional landmark-based IVs fail 33–69% of the time
Nearly 50% of catheters are removed unintentionally
Repeated failed attempts drive unnecessary central line placement
The “escalation problem” occurs when failed PIV attempts lead to PICCs or central lines
Central access increases risk for:
CLABSIs
Thrombosis
Mechanical complications
Ultrasound-guided PIVs act as a rescue strategy, not a luxury
Moves IV insertion from tactile guessing to visual confirmation
Allows assessment of:
Vessel depth
Diameter
Vein wall health
First-attempt success increases to 91–98%
Short-axis (“donut view”) preferred for peripheral IVs
Master the creep method:
Advance needle → stop
Slide probe → advance needle
Repeat until lumen entry
Critical insight:
A flash means the needle is in the vein
The catheter may not be
Advance the entire device further before threading
Basilic and brachial veins:
Larger diameter
More stable
Less nerve density
Fewer infiltrations, longer dwell times, less patient pain
Identifies difficult access before attempts begin
Risk factors include:
Obesity
Edema
Dehydration
Frequent hospitalizations
IV drug history
Score ≥3 → skip blind attempts and escalate early
Inefficient IV access costs $1.5 billion annually
Specialized teams save:
~$83 per patient
~$45,000 per CLABSI prevented
Faster access = better bedside nurse productivity
Midlines can last up to 29 days
Ideal for week-long therapies
Shift away from routine 72-hour replacement
Preserve vessels, supplies, and patient comfort
Helps visualize superficial veins
Improves equity across skin tones
Best used as an assessment tool, not placement replacement
Blind IV starts fail too often to be ignored
Ultrasound isn’t advanced practice — it’s evolving standard care
A flash is not the finish line
DIVA scoring protects both patients and nurses
Vascular access is about vein preservation, not just “getting a line”
Host 1: Hello and welcome. You are listening to a special episode of the Super Nurse podcast.
Host 2: Hello.
Host 1: I am really, uh, looking forward to today's session. We are dissecting a skill that sits right at the intersection of, you know, manual dexterity, patient safety, and high-tech nursing. It is arguably one of the most fundamental skills in our scope of practice, but the data suggests it's also one of the most complex to perform consistently well. And we are talking about vascular access. But before we get into the weeds of the technique, we have to give credit where it's due.
Host 2: Absolutely. This episode of the Super Nurse podcast was created by Brooke Wallace. She's a 20-year ICU nurse, organ transplant coordinator, clinical instructor, and a published author.
Host 1: That is an incredibly impressive clinical background. And that depth, it really shows in the material we're covering today.
Host 2: It really does. And hey, if you're listening right now, do yourself a favor and hit that subscribe button immediately so you never miss an episode. We have a lot of these high-yield breakdowns coming your way.
Host 1: Oh, sure. Now, just a quick disclaimer. Before we get rolling, we are not Brooke Wallace, right? We are your AI-powered guides here to analyze the research and help you become a super nurse. Think of us as your digital journal club. We're sifting through the evidence so you can apply it at the bedside.
Host 2: Exactly. So, let's set the stage. I don't want to just talk about starting an IV in the abstract. I want to talk about the pin cushion effect. We've all been there.
Host 1: Oh, yes. You have a patient and, um, maybe they're dehydrated, elderly, or they have a history of IV drug use. You stick, you miss. You stick again, you miss. You can feel the patient wincing. The family is watching, and the trust in the room just evaporates. It's a visceral feeling of failure.
Host 2: Right? And what's interesting is that in nursing culture, we often treat that scenario as just bad luck or bad veins. But the mission of today's session is to reframe that entirely. We're looking at moving beyond the blind stick.
Host 1: Exactly. We're exploring the shift toward ultrasound-guided peripheral IV insertions, or USGPIV, and the rise of specialized vascular access teams, or VASTs. The central argument in the research is that the blind stick isn't just old school. In many patient populations, it's actually clinically inefficient and potentially harmful.
Host 2: That is a strong stance.
Host 1: It is, but the numbers back it up. We are looking at over 2 billion peripheral catheters inserted globally every year.
Host 2: Two billion. It is the most common invasive procedure in healthcare. Period.
Host 1: And yet looking at the data, the failure rates are... well, they're shockingly high for something so common.
Host 2: They are. When we look at the aggregated research, the failure rate for traditional blind PIVs ranges anywhere from 33 to 69%.
Host 1: Wait, 69%? That's more than half. That means in some patient cohorts you are statistically more likely to fail than succeed before the therapy is even completed.
Host 2: That's right. And when we say fail, we aren't just talking about missing the vein on insertion.
Host 1: No, we're talking about the line infiltrating, dislodging, or developing phlebitis before the medication is done running.
Host 2: Correct. Nearly 50% of catheters are removed unintentionally. And this leads us to what the research calls the escalation problem.
Host 1: This is a key concept. It is when a bedside nurse fails three or four times. They don't just keep sticking indefinitely. They escalate.
Host 2: Right? They call the MD or the PICC team and say this patient has no access. We need a central line. But here is the tragedy. The patient often doesn't need central access for the medication. They just need access period. So we end up placing a central venous catheter or a PICC line solely because we couldn't find a peripheral vein.
Host 1: Which introduces a whole new, much higher risk profile for the patient.
Host 2: Massive risks. We're talking CLABSIs—central line-associated bloodstream infections—thrombosis, even pneumothorax during insertion. The research is explicit here. Using ultrasound guidance for peripheral lines acts as a rescue strategy.
Host 1: A rescue?
Host 2: Yes. It significantly reduces the unnecessary placement of central lines. You are using better tech to keep the procedure less invasive.
Host 1: So let's pivot to that technology. For the nurse who sees the ultrasound machine as this scary expensive cart in the corner, what is actually happening when you pick up that probe?
Host 2: Fundamentally, you are moving from a tactile procedure to a visual one.
Host 1: From feel to sight.
Host 2: Exactly. In a blind stick, you're relying on landmarks and rebound. You're feeling for that bounce. With ultrasound, you are literally looking inside the arm. You can see the depth of the vessel, the diameter, and crucially, the health of the vein wall.
Host 1: And the difference in outcomes is stark. I was looking at the comparison between generalists and specialists. The gap is undeniable. For a generalist—so, your typical bedside nurse using the landmark method—first attempt success rates are highly variable, usually hovering between 44 and 76%. In difficult patients, that's basically a coin flip.
Host 2: Essentially. Yes. And for the specialist using ultrasound guidance, the first attempt success jumps to between 91 and 98%.
Host 1: That isn't just a marginal improvement. That is a completely different standard of care.
Host 2: It is. And it's not just about hitting a vein. It's about hitting the right vein. The research discusses how ultrasound opens up real estate that is invisible to the naked eye and touch. We're talking deep veins.
Host 1: We're talking the deep veins, the basilic and the brachial veins in the upper arm. Why are those targets better than, say, the cephalic vein in the forearm or a vein in the hand?
Host 2: A few reasons. First, they are generally larger. Second, because they are deeper, they are surrounded by more tissue, which makes them more stable and less prone to being dislodged.
Host 1: Right. Compared to a superficial vein in the wrist or hand.
Host 2: Exactly. You are sparing the patient the pain of hand IVs, which have higher nerve density, and you're placing a line that is mechanically more likely to survive the duration of therapy.
Host 1: Okay, so the why is obvious. Better success, better veins, happier patients. But the "how" is where I think a lot of listeners get stuck.
Host 2: That's the number one hurdle. I've heard nurses say, "I tried the ultrasound, but I lose the needle on the screen and it's disorienting."
Host 1: It is disorienting at first. So, let's break down the technique cheats in training. The research, particularly the "how I teach" articles, emphasize that this is a distinct motor skill. It's not just looking and sticking. So, let's start with the views. We hear about short axis versus long axis, right?
Host 2: Short axis is what we call the donut view. You're cutting the vein in a cross-section. So, it looks like a black circle on the screen.
Host 1: Okay. Donut.
Host 2: Long axis is the longitudinal view where the vein looks like a set of train tracks or a long tube.
Host 1: And the consensus seems to be that short axis is the place to start for PIVs.
Host 2: Yes, for peripheral IVs, short axis is generally preferred for the initial puncture because you can see the vein's relationship to surrounding arteries and nerves more clearly. You center the target. But—and this is the big but—you have to master the creep method to track the needle.
Host 1: The creep. Okay, walk us through this step by step. This seems to be the secret sauce.
Host 2: It's a coordination drill. So, imagine you have the vein centered on your screen, the black donut. You poke the skin. You advance your needle slightly. On the screen, you will see a bright white dot appear above the vein.
Host 1: That's the needle tip.
Host 2: That is your needle tip. Now, stop moving the needle. This is where people mess up. Okay? If you keep pushing the needle without moving the probe, you will drive it right through the back wall of the vein because the ultrasound beam is only a thin slice of reality. You have to creep the probe.
Host 1: So, you slide the ultrasound probe forward on the arm just a millimeter or two until that white dot disappears. So, move the camera ahead of the needle.
Host 2: Exactly. Now, you hold the probe still and advance the needle again until the white dot reappears.
Host 1: So, you're leapfrogging.
Host 2: They were playing leapfrog. Probe forward, needle forward, probe forward, needle forward. You track that tip all the way until it pops into the lumen of the vein. And once you're in, you get that satisfying blood return in the chamber, the flash.
Host 1: And here is the most critical insight from the literature. This is where 90% of failures happen after a successful stick. You see the flash, you get excited, and you immediately try to thread the catheter off the needle.
Host 2: And it hits resistance. It won't thread, or worse, the vein blows immediately, right?
Host 1: I mean, why does that happen? It's simple geometry. The plastic catheter sits slightly behind the sharp needle tip. So when you get a flash, the needle tip is inside the vein, but the catheter tip is still just outside the vein wall.
Host 2: Precisely. So, if you thread now, you're just jamming the plastic catheter against the outside wall of the vein. You're pushing a blunt object against the vessel.
Host 1: That is such a crucial visual.
Host 2: The research instruction is very specific here. Advance the needle and catheter device almost entirely into the vessel before threading.
Host 1: Almost entirely. That feels so wrong if you're used to blind sticks where you stop as soon as you get blood.
Host 2: It feels wrong, but under ultrasound, you can see the needle inside that black circle. You know you are safe. Advance the whole assembly another few millimeters, even a centimeter, to ensure the plastic catheter has crossed into the lumen. Then thread.
Host 1: That single tip probably saves more lines than anything else. It is the difference between a flash and a functional line.
Host 2: But you know, we can't teach this through a podcast. The research mentions programs like Operation Estic, right? You need phantom arms and supervised practice. You can't learn this on live patients.
Host 1: No, you need that feedback loop of simulation to build the hand-eye coordination without the stress. So let's look at the decision-making. We know ultrasound is superior, but we can't use it on every single patient who walks through the door. Or can we? How do we triage?
Host 2: That brings us to the DIVA score. DIVA, which stands for Difficult Intravenous Access.
Host 1: Right. The goal is to objectively identify the hard stick before you ever uncap a needle. The research highlights risk factors we all know intuitively: obesity, edema, dehydration, sickle cell disease, a history of IV drug abuse...
Host 2: And frequent hospitalizations which leads to venous depletion. The veins are just scarred down from overuse.
Host 1: Okay. So, the DIVA score assigns points for things like is the vein palpable? Is it visible?
Host 2: Exactly. If I can't see it and I can't feel it, the score goes up.
Host 1: And what's the threshold?
Host 2: The literature suggests that a score of three or higher is the tipping point. If a patient scores a 3 plus, you should trigger a protocol. Skip the blind attempts. Stop poking.
Host 1: Stop poking. Go straight to ultrasound guidance or call a specialist. I love that because it removes the ego. It's not "I'm a bad nurse if I can't get this." It's "This patient has a DIVA score of four. The protocol says I need help."
Host 2: It standardizes compassion. It saves the patient pain and it saves the nurse time.
Host 1: Speaking of saving time, let's talk about the people you call. Let's talk about VASTs—vascular access specialist teams. This is a huge organizational shift. Instead of vascular access being everyone's job, which usually means it's nobody's mastercraft, it becomes the sole focus of a dedicated team.
Host 2: Okay, but I can already hear the hospital administrators listening. They're thinking, "Great, you want me to hire a whole new team of specialized nurses just to start IVs? I can't afford that."
Host 1: And the counterargument from the research is you can't afford not to. The cost-benefit analysis is robust. Inefficient IV access costs the US healthcare system about $1.5 billion annually.
Host 2: That is a massive inefficiency tax.
Host 1: It is. The Operation Estic program broke it down to a savings of $83.18 per patient when a specialized approach was used.
Host 2: $83 per patient doesn't sound huge, but multiply that by thousands of admissions.
Host 1: Exactly. And another European study showed savings of roughly €10 million. And that money comes from preventing the expensive complications. If a VAST prevents one case of CLABSI, that bloodstream infection, that saves the hospital roughly $45,000 immediately.
Host 2: Wow. Plus the efficiency factor. If I'm a bedside nurse and I spend 45 minutes struggling to get an IV, that is 45 minutes I'm not doing other things.
Host 1: It's a productivity drain. A specialist can often come in, assess, and place a line in 10 minutes. And they aren't just placing standard IVs. They're often placing midline catheters.
Host 2: All right. Explain the midline advantage.
Host 1: A midline is a longer catheter. It goes in the upper arm, and the tip sits in the axillary vein, but it doesn't go all the way to the heart like a PICC. These can last up to 29 days.
Host 2: So for a patient with pneumonia who's there for a week, one stick lasts the whole stay.
Host 1: Precisely. Which brings us to a quick policy point. The shift from routine replacement to clinically indicated replacement.
Host 2: The old rule: change the PIV every 72 or 96 hours, no matter what. I remember pulling perfectly good IVs just because the date was up, right? A timer-based policy.
Host 1: The new research supports clinically indicated replacement, meaning if it ain't broke, don't fix it. If the site is soft, dry, patent, leave it alone.
Host 2: This just makes so much more sense. It prevents us from damaging more vessels and consuming more supplies.
Host 1: Exactly. But it only works if you have rigorous monitoring. And that's where a VAST team can really own that surveillance.
Host 2: Before we wrap up, the research touched on one other piece of tech: near infrared.
Host 1: Yes, NIR or vein visualization. It projects a map of superficial veins onto the skin. It's not as good as ultrasound because it doesn't show depth or blood flow. But it is excellent for assessment.
Host 2: And the research pointed out it's an equity tool.
Host 1: It is. It helps visualize veins regardless of skin pigmentation, ensuring fair care for all patients.
Host 2: That is a fantastic point. Using technology to level the playing field. Okay, we have covered a massive amount of ground. Let's distill this—key takeaways for our listener.
Host 1: Four main points. Number one: the blind stick failure rate is unacceptably high, up to 69%. We have to acknowledge the old way is failing our patients.
Host 2: Number two: Ultrasound guidance is the solution. It bumps success to 98%. But you have to master the specific motor skills like the creep method. And remember the geometry: do not thread immediately on the flash. Advance the catheter almost entirely into the vessel first.
Host 1: Number three: use the DIVA score. If the score is three or higher, stop poking. Escalation is not a failure, it's a strategy.
Host 2: And number four: vascular access teams pay for themselves. They save money, time, and patient veins. This really changes the conversation from starting a line to preserving vascular health.
Host 1: Absolutely. So, I'll leave you with this final thought. We've established that ultrasound is safer, cheaper, and more effective. We wouldn't listen to a heart murmur by putting our ear against a patient's chest anymore. We use a stethoscope.
Host 2: That would be absurd.
Host 1: So, why are we still feeling for veins with our fingers when we have the technology to see them? The future of nursing likely involves the ultrasound probe becoming as common as the stethoscope. The question is, are you ready to learn it?
Host 2: That is the challenge for the week. Thank you so much for joining us on this episode of the Super Nurse podcast.
Host 1: It's been a pleasure.
Host 2: And hey, if this conversation sparked a desire to level up your skills, we create AI-powered courses to empower the next generation of super nurses just like you. Go to supernurse.ai right now. That's supernurse.ai for AI-powered courses, an amazing community, and superpowered nursing resources. Thanks for listening, and until next time, stay super.